Suboptimal erythropoietic response to hypoxemia in idiopathic pulmonary fibrosis

Chest

Volumn 124, Issue 2, 2003, Pages 548-553

  Tsantes, Argirios ^a,d   Tassiopoulos, Stergios ^b   Papadhimitriou, Stefanos I ^a   Bonovas, Stefanos ^a   Kavalierou, Lilian ^c   Vaiopoulos, George ^b   Meletis, Ioannis ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Third Regl Blood Transfusion Center   (Greece)

^d NONE   (Greece)

Author keywords

Chronic inflammation; Cytokines; Idiopathic pulmonary fibrosis; Ineffective erythropoiesis

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 6; INTERLEUKIN 8; METHYLCELLULOSE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BURST FORMING UNIT E; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROPOIESIS; FEMALE; GAS EXCHANGE; GROWTH INHIBITION; HEMOGLOBIN DETERMINATION; HUMAN; HYPOXEMIA; IMMUNOPATHOLOGY; INFLAMMATION; LUNG FIBROSIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0041731568     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.2.548     Document Type: Article

References (28)

1. Toews BG. Interstitial lung disease. In: Goldman L, Bennett JC, eds. Cecil textbook of medicine, 21st ed. Philadelphia, PA: WB Saunders, 2000; 409-419
2. Reynolds HY. Interstitial lung diseases. In: Isselbacher KJ, Braunwald E, Wilson JD, et al, eds. Harrison's principles of internal medicine, 13th ed. New York, NY: McGraw-Hill, 1994; 1206-1211
3. Nathan CF. Secretory products of macrophages. J Clin Invest 1986; 79:319-326
4. Livingstone JL, Lewis JG, Reid L, et al. Diffuse interstitial pulmonary fibrosis. Q J Med 1964; 33:71-103
5. Crystal RG. Idiopathic pulmonary fibrosis. Ann Intern Med 1976; 85:769-788
6. Tassiopoulos S, Kontos A, Konstantopoulos K, et al. Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 2001; 95:471-475
7. Papayannopoulou T, Brice M, Blau A. Kit ligand in synergy with interleukin-3 amplifies the erythropoietin-independent globin synthesizing progeny of normal human burst-forming units-erythroid in suspension cultures: physiologic implications. Blood 1993; 81:299-310
8. Papayannopoulou T, Abkowitz J, D'Andrea A. Biology of erythropoiesis, erythroid differentiation and maturation. In: Hoffman B, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: basic principles and practice. 3rd ed. New York, NY: Churchill-Livingstone, 2000; 202-219
9. Johnson BA, Waddelow TA, Caro J, et al. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 1989; 74:130-138
10. Maciejewski J, Selleri C, Anderson S, et al. Fas antigen expression on CD34+ human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995; 85:3183-3190
11. Means BT, Dessypris EN, Krantz SB. Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. J Clin Invest 1990; 86:538-541
12. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79:1987-1994
13. Mamus SW, Beck-Schroeder S, Zanjani ED. Suppression of normal human erythropoiesis by γ interferon in vitro: role of monocytes and T-lymphocytes. J Clin Invest 1985; 75:1496-1503
14. Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by interferons α and β: differing mechanisms despite shared receptor. Exp Hematol 1996; 24:204-208
15. Dai CH, Price JO, Brunner T, et al. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon γ to produce erythroid cell apoptosis. Blood 1998; 91:1235-1242
16. Nagafugi K, Shibuya T, Harada M, et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995; 86:883-889
17. Ulich TR, Castillo J, Yin S. Tumor necrosis factor exerts dose-dependent effects on erythropoiesis and myelopoiesis in vivo. Exp Hematol 1990; 18:311-315
18. Johnson CS, Keckler DJ, Topper MI, et al. In vivo hematopoietic effects of recombinant interleukin-1 in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood 1989; 73:678-683
19. Schooley JC, Kullgren B, Allison AC. Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anemias. Br J Haematol 1987; 67:11-17
20. Ogava M, Parmley B, Bank H, et al. Human marrow erythropoiesis in culture: characterization of methylcellulose colony assay. Blood 1976; 48:407-417
21. Tepperman AD, Curtis JE, McCulloch EA. Erythropoietic colonies in cultures of human marrow. Blood 1974; 44:659-669
22. Thrall RS, Vogel SN, Evans R, et al. Role of tumor necrosis factor-α in the spontaneous development of pulmonary fibrosis in viable moth-eaten mutant mice. Am J Pathol 1997; 151:1303-1310
23. Ziegenhagen MW, Zabel P, Zissel G, et al. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med 1998; 157:762-768
24. Ziegenhagen MW, Schrums S, Zissel G, et al. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. J Investig Med 1998; 46:223-231
25. Gregoli PA, Bondurant MC. The roles of Bcl-XL and apopain in the control of erythropoiesis by erythropoietin. Blood 1997; 90:630-640
26. De Maria R, Testa U, Luchetti L, et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 1999; 93:796-803
27. Cazzola M, Guarnone R, Cerani P, et al. Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood 1998; 91:2139-2145
28. Johnson CS, Cook CA, Furmanski P. In vivo suppression of erythropoiesis by tumor necrosis factor-α (TNF-α): reversal with exogenous erythropoietin. Exp Hematol 1989; 18:109-113